Minireviews
Copyright ©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2053-2063
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2053
Table 2 Target genes for treating gall bladder cancer (under investigation and those under clinical trial)
Target genes silenced by siRNA (under investigation)
Target genes for GBC treatment (under clinical trial)
BMI1, CD44, CLIC1, JAB1, EGFREGFR and Her/2 together (Afatnib-NCT04183712, Apatinib-NCT03702491)
HER 2/neu, ARAFHER/2 (Trastuzumab-NCT00478140)
MIFMEK (Trametinib-NCT02042443)
CD73, PDL1DNMT (Guadecitabine-NCT03257761)